| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +4% |
| 3Y CAGR | +2% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +7.0% |
| 3Y CAGR | +5% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,711.20 +193.80 (7.70%) | 20,606.39 | 30.39 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,917.00 -34.50 (0.50%) | 17,317.75 | 102.09 | 19.84 | ||
Natco PharmaNATCOPHARM | ₹849.20 +7.70 (0.92%) | 15,211.80 | 13.29 | 1.65 | ||
Marksans PharmaMARKSANS | ₹322.40 +0.80 (0.25%) | 14,612.26 | 28.04 | 4.83 |